S 22

  • Vermont Senate Bill
  • 2021-2022 Regular Session
  • Introduced in Senate Jan 13, 2021
  • Passed Senate Mar 11, 2021
  • House
  • Governor

An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Abstract

Bill Sponsors (2)

Virginia Lyons

     
Primary

Richard McCormack

     
Cosponsor

Votes


No votes to display

Actions


Mar 16, 2021

House

Read First Time and Referred to the Committee on Health Care

Mar 11, 2021

Senate

Read 3rd time & passed

Senate

New Business/Third Reading

Mar 10, 2021

Senate

Recommendation of amendment by Committee on Health and Welfare agreed to

Senate

Read second time, reported favorably with recommendation of amendment by Senator Hooker for Committee on Health and Welfare

Senate

New Business/Second Reading

Senate

Favorable report with recommendation of amendment by Committee on Health and Welfare

Senate

3rd reading ordered

Mar 09, 2021

Senate

Entered on Notice Calendar

Senate

Favorable report with recommendation of amendment by Committee on Health and Welfare

Jan 13, 2021

Senate

Read 1st time & referred to Committee on Health and Welfare

Bill Text

Bill Text Versions Format
As Introduced PDF
Official PDF
Unofficial PDF

Related Documents

Document Format
Committee Meetings HTML
Witness List HTML

Sources

Data on Open States is updated nightly from the official website of the Vermont General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.